BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Biodefense - ECPv6.18.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://globalbiodefense.com
X-WR-CALDESC:Events for Global Biodefense
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210309T160000
DTEND;TZID=America/New_York:20210309T180000
DTSTAMP:20210225T163128Z
CREATED:20210225T155238Z
LAST-MODIFIED:20210225T163128Z
UID:48625-1615305600-1615312800@globalbiodefense.com
SUMMARY:Ethics in Vaccine Development\, Testing and Use Making a COVID-19 Vaccine
DESCRIPTION:A virtual presentation on “Ethics in Vaccine Development\, Testing and Use Making a COVID-19 Vaccine” will be held on March 9\, 2021 as part of the 2021 Demystifying Medicine Series. \nThe 2021 Demystifying Medicine Series\, which is jointly sponsored by FAES and NIH\, will begin January 12 and includes the presentation of patients\, pathology\, diagnosis and therapy in the context of major disease problems and current research. Primarily directed toward Ph.D. students\, clinicians and program managers\, the course is designed to help bridge the gap between advances in biology and their application to major human diseases. Each session includes clinical and basic science components presented by NIH staff and invitees. All students\, fellows and staff are welcome\, as well. \nAbout the Speakers \nKizzmekia Corbett\, PhD is a research fellow and the scientific lead for the Coronavirus Vaccines & Immunopathogenesis Team at the National Institutes of Health (NIH)\, National Institute of Allergy and Infectious Diseases\, Vaccine Research Center (VRC). She received a B.S. in Biological Sciences\, with a secondary major in Sociology\, in 2008 from the University of Maryland – Baltimore County\, where she was a Meyerhoff Scholar and an NIH undergraduate scholar. She then enrolled at University of North Carolina at Chapel Hill\, where she obtained her Ph.D. in Microbiology and Immunology in 2014. A viral immunologist by training\, Dr. Corbett uses her expertise to propel novel vaccine development for pandemic preparedness. Appointed to the VRC in 2014\, her work focuses on developing novel coronavirus vaccines\, including mRNA-1273\, a leading candidate vaccine against the virus that causes COVID-19. In response to the ongoing global COVID-19 pandemic\, the vaccine concept incorporated in mRNA-1273 was designed by Dr. Corbett’s team from viral sequence data and rapidly deployed to industry partner\, Moderna\, Inc.\, for U.S. Food and Drug Administration (FDA)-approved Phase 1 clinical trial\, which unprecedently began only 66 days from the viral sequence release. Following promising results in animal models and humans\, mRNA-1273 is currently in Phase 3 clinical trial. Alongside mRNA-1273\, Dr. Corbett’s team boasts a portfolio that also includes universal coronavirus vaccine concepts and novel therapeutic antibodies. Additionally\, Dr. Corbett spent several years working on a universal influenza vaccine\, which is slated for Phase 1 clinical trial. In all\, she has 15 years of expertise studying dengue virus\, respiratory syncytial virus\, influenza virus and coronaviruses. Along with her research activities\, Dr. Corbett is an active member of the NIH Fellows Committee and avid advocator of STEM education and vaccine awareness in the community. Combining her research goals with her knack for mentoring\, Dr. Corbett aims to become an independent principal investigator. \nChristine Grady\, PhD is a nurse-bioethicist and a senior investigator who currently serves as the Chief of the Department of Bioethics. Dr. Grady has authored more than 175 papers in the biomedical and bioethics literature and authored or edited several books\, including The Oxford Textbook of Clinical Research Ethics. She served from 2010-2017 as a Commissioner on the President’s Commission for the Study of Bioethical Issues. Her work is known internationally\, and she has lectured widely on ethical issues in clinical research and clinical care\, HIV disease\, and nursing. She is an elected fellow of the Hastings Center and of the American Academy of Nursing\, a senior research fellow at the Kennedy Institute of Ethics and an elected member of the National Academy of Medicine. She holds a BS in nursing and biology from Georgetown University\, a MSN. in community health nursing from Boston College\, and a PhD in philosophy from Georgetown University. She has participated in numerous intergovernmental task forces and is the recipient of several awards\, including the NIH CEO Award in 2017\, and the NIH Director’s Award in 2015 and 2017. \nPlease visit the NIH Demystifying Medicine website for more information.
URL:https://globalbiodefense.com/event/ethics-in-vaccine-development-testing-and-use-making-a-covid-19-vaccine/
CATEGORIES:Government Hosted,Webinar-Webcast,Workshop
LOCATION:https://videocast.nih.gov/watch=41289
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210304T120000
DTEND;TZID=America/New_York:20210304T130000
DTSTAMP:20210226T161901Z
CREATED:20210126T161411Z
LAST-MODIFIED:20210226T161901Z
UID:48672-1614859200-1614862800@globalbiodefense.com
SUMMARY:Integrating Inflammation and Coagulation in COVID-19
DESCRIPTION:The National Institutes of Health COVID-19 Scientific Interest Group will host a webcast on Integrating Inflammation and Coagulation in COVID-19 on March 4\, 2021. \nAbout the Speaker \nYogen Kanthi\, M.D.\, NHLBI Lasker Scholar\, NIH \nSpeaker Yogen Kanthi is a cardiologist and clinical vascular medicine specialist. His laboratory aims to understand how inflammation and coagulation contribute to vascular disease. He is interested in developing a deeper understanding of how innate immune circuits and communicate with coagulation and the vessel wall to license or restrict thrombosis. \nPlease visit the NIH VideoCast website for more information.
URL:https://globalbiodefense.com/event/integrating-inflammation-and-coagulation-in-covid-19/
CATEGORIES:Government Hosted,Webinar-Webcast
LOCATION:https://videocast.nih.gov/watch=41450
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210302T160000
DTEND;TZID=America/New_York:20210302T180000
DTSTAMP:20210225T162756Z
CREATED:20210225T154652Z
LAST-MODIFIED:20210225T162756Z
UID:48622-1614700800-1614708000@globalbiodefense.com
SUMMARY:RNA Viruses: How They Do What They Do
DESCRIPTION:A virtual presentation on “RNA Viruses: How They Do What They Do” will be held on March 2\, 2021 as part of the 2021 Demystifying Medicine Series. \nThe 2021 Demystifying Medicine Series\, which is jointly sponsored by FAES and NIH\, will begin January 12 and includes the presentation of patients\, pathology\, diagnosis and therapy in the context of major disease problems and current research. Primarily directed toward Ph.D. students\, clinicians and program managers\, the course is designed to help bridge the gap between advances in biology and their application to major human diseases. Each session includes clinical and basic science components presented by NIH staff and invitees. All students\, fellows and staff are welcome\, as well. \nAbout the Speakers \nDr. Nihal Altan-Bonnet received her B.A. in biology and chemistry from Hunter College\, New York in 1992 and her Ph.D. in cell biology from The Rockefeller University in 1998. She then conducted postdoctoral research with Dr. Jennifer Lippincott-Schwartz at the National Institute of Child Health and Development at the NIH from 1999 to 2005 before receiving a faculty position in the department of biological sciences at Rutgers University. In 2013\, Dr. Altan-Bonnet returned to the NIH as an Earl Stadtman Investigator\, becoming head of the Laboratory of Host-Pathogen Dynamics at the NHLBI and was promoted to tenured Senior investigator in 2017. Dr. Altan-Bonnet has been recognized several times for her outstanding research\, receiving the Presidential Early Career Award in Science and Engineering (PECASE) in 2012\, being named the John J. Holland lecturer at the American Society of Virology in 2017\, and receiving the Norman Salzman Mentor Award in Virology in 2018. Dr. Altan-Bonnet was also named a Kavli Fellow and Scialog Fellow from 2013-2016. She is an Associate editor at the Molecular Biology of the Cell and is a member of the American Societies for Virology\, Microbiology\, and Cell Biology. \nKarla Kirkegaard\, Ph.D.\, is the Violetta L. Horton Research Professor of Genetics and former Chair of the Department of Microbiology and Immunology in the Stanford University School of Medicine. She received her Ph.D. in Biochemistry and Molecular Biology with James C. Wang at Harvard University\, and performed her postdoctoral work in the laboratory of David Baltimore at the Whitehead Institute. As an Assistant and Associate Professor at the University of Colorado in Boulder\, she received numerous awards\, including a fellowship from the David and Lucile Packard Foundation\, an American Cancer Society Young Investigator Award\, a Searle Scholar Award\, and sponsorship by the Howard Hughes Medical Institute. Dr. Kirkegaard combined her interests in biochemistry\, cell biology\, and genetics in the study of RNA virology\, using poliovirus and other positive-strand RNA viruses to understand the cell biology of viral infections and the genetics of viral variability. Since her move to Stanford University School of Medicine in 1996\, her interests have focused increasingly on the impact of basic science discoveries on the transmission of viruses in infected hosts. Kirkegaard’s honors include an Ellison Foundation Senior Scholar Award in Global Infectious Disease and\, in 2006\, the NIH Director’s Pioneer Award\, for her approach to guide the selection of antiviral targets with the goal of suppressing the drug-resistant RNA genomes that will inevitably be formed due to the high error rates of RNA replication. She has been recently elected as a Member of the National Academies of Arts and Sciences and a Fellow of the American Association for the Advancement of Science. Her work continues to focus on the mechanisms of diversity and propagation of viruses and suppression of this diversity and spread. \nPlease visit the NIH Demystifying Medicine website for more information.
URL:https://globalbiodefense.com/event/rna-viruses-how-they-do-what-they-do/
CATEGORIES:Government Hosted,Webinar-Webcast,Workshop
LOCATION:https://videocast.nih.gov/watch=41288
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210203T140000
DTEND;TZID=America/New_York:20210203T150000
DTSTAMP:20210130T234651Z
CREATED:20210130T234547Z
LAST-MODIFIED:20210130T234651Z
UID:48420-1612360800-1612364400@globalbiodefense.com
SUMMARY:ZOHU Call - Zoonoses & One Health Updates
DESCRIPTION:Zoonoses & One Health Updates (ZOHU) Calls are one-hour monthly webinars that provide timely education on zoonotic and infectious diseases\, One Health\, antimicrobial resistance\, food safety\, vector-borne diseases\, recent outbreaks\, and related health threats at the animal-human-environment interface.\n\nThe following is the agenda for the February 3\, 2021 ZOHU Call:\n\nOne Health News from CDC\nCasey Barton Behravesh\, MS\, DVM\, DrPH\, DACVPM\nCaptain\, U.S. Public Health Service\nDirector\, One Health Office\nCenters for Disease Control and Prevention\ndlx9@cdc.gov \nNASA and NOAA Earth Observations for Health and Air Quality Application\nJohn Haynes\, MS\nProgram Manager\, Health and Air Quality Applications\nNational Aeronautics and Space Administration Earth Science Division\njhaynes@nasa.gov\nAND\nJuli M. Trtanj\, MES\nNOAA One Health and Integrated Climate Research Lead\nNational Oceanic and Atmospheric Administration Climate Program Office\njuli.trtanj@noaa.gov \nSurveillance for Harmful Algal Bloom Events and Associated Human and Animal Illnesses — One Health Harmful Algal Bloom System\, United States\, 2016–2018\nVirginia A. Roberts\, MSPH\nEpidemiologist\nWaterborne Disease Prevention Branch\nNational Center for Emerging and Zoonotic Infectious Diseases\nCenters for Disease Control and Prevention\nevl1@cdc.gov \nExploration of Decontamination Strategies for Odor Detection Canines\nJulia Patrone\, PhD\nSenior Scientist\nJohns Hopkins Applied Physics Laboratory\njulia.patrone@jhuapl.edu\nAND\nKaren Meidenbauer DVM\, MPH\nSenior Scientist/Veterinarian\nJohns Hopkins Applied Physics Laboratory\nkaren.meidenbauer@jhuapl.edu \nThe target audience for ZOHU Calls include: \n\nAcademics\nAdministrators\nAgriculture\nAnimal health officials\nAnimal industry\nEnvironmental health professionals\nEpidemiologists\nHealth educators and communicators\nHuman health professionals\nLaboratorians\nNon-governmental organizations\nProgram managers\nPublic health professionals\nStudents\nVeterinarians/vet technicians\nWildlife officials\n\n\nA captioned recording will be posted within 30 days after the call.
URL:https://globalbiodefense.com/event/zohu-call-zoonoses-one-health-updates/
CATEGORIES:Conference,Government Hosted,Webinar-Webcast
LOCATION:https://cdc.zoomgov.com/j/1611576470?pwd=bUxSZGk3TCt5dGhCSkg5cko1dGk5Zz09
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210119T160000
DTEND;TZID=America/New_York:20210119T180000
DTSTAMP:20210225T162543Z
CREATED:20210225T162543Z
LAST-MODIFIED:20210225T162543Z
UID:48635-1611072000-1611079200@globalbiodefense.com
SUMMARY:Immunological and Genetic Features of COVID-19 and Rapid Vaccine Development
DESCRIPTION:A virtual presentation on “Immunological and Genetic Features of COVID-19 and Rapid Vaccine Development” will be held on January 19\, 2021 as part of the 2021 Demystifying Medicine Series. \nThe 2021 Demystifying Medicine Series\, which is jointly sponsored by FAES and NIH\, will begin January 12 and includes the presentation of patients\, pathology\, diagnosis and therapy in the context of major disease problems and current research. Primarily directed toward Ph.D. students\, clinicians and program managers\, the course is designed to help bridge the gap between advances in biology and their application to major human diseases. Each session includes clinical and basic science components presented by NIH staff and invitees. All students\, fellows and staff are welcome\, as well. \nAbout the Speakers: \nLuigi Daniele Notarangelo\, M.D. is Senior Investigator\, Immune Deficiency Genetics Section\, NIAID/DIR. The main goal of the Immune Deficiency Genetics Section (IDGS) is to characterize the molecular and cellular mechanisms underlying primary immune deficiencies\, and combined immunodeficiencies (CID) in particular\, with the ultimate objective of improving diagnosis and treatment of these conditions. Luigi D. Notarangelo received his M.D. from the University of Pavia\, Italy. After completing training in pediatrics\, subspecialty training in allergy/immunology\, and human genetics at the University of Pavia and a postdoctoral internship with David Nelson\, M.D.\, at the Metabolism Branch\, National Cancer Institute\, he was appointed associate professor and subsequently full professor of pediatrics at the University of Brescia\, Italy\, where he chaired the department of pediatrics between 2000 and 2006. In November 2006\, he joined the division of immunology at Boston Children’s Hospital\, Harvard Medical School\, as professor of pediatrics. In October 2016\, he joined the Laboratory of Host Defenses. Dr. Notarangelo is a leader in the study of the molecular and cellular mechanisms of human primary immune deficiencies and in the treatment of these disorders. He has served as president of the European Society for Immune Deficiencies and of the Clinical Immunology Society. He has received numerous national and international awards. \nBarney S. Graham\, M.D.\, Ph.D. is Senior Investigator\, Viral Pathogenesis Laboratory and Translational Science Core\, NIAID Vaccine Research Center (VRC). Dr. Graham serves as Deputy Director of the NIAID Vaccine Research Center and assists the Director in establishing and focusing the scientific direction for the VRC as a premier intramural research organization. As Chief of the Viral Pathogenesis Laboratory\, Dr. Graham also leads the development efforts for COVID-19 vaccines and universal influenza vaccines. In addition\, he supports VRC product development through strategic advice on vaccine design as well as pre-clinical and clinical evaluation. Dr. Graham is an immunologist\, virologist\, and clinical trials physician whose primary interests are viral pathogenesis\, immunity\, and vaccine development. His laboratory is focused on respiratory viral pathogens\, pandemic preparedness\, and emerging viral diseases. He applies structural biology\, protein engineering\, and other new technologies to create vaccines for unmet needs and emerging threats advancing the principles of precision vaccinology. He has been involved in the clinical evaluation of candidate vaccines for more than 30 years and has an ongoing interest in science education and expanding research opportunities for underrepresented minorities. \nPlease visit the NIH Demystifying Medicine website for more information.
URL:https://globalbiodefense.com/event/immunological-and-genetic-features-of-covid-19-and-rapid-vaccine-development/
CATEGORIES:Government Hosted,Webinar-Webcast,Workshop
LOCATION:https://videocast.nih.gov/watch=41282
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210112T160000
DTEND;TZID=America/New_York:20210112T173000
DTSTAMP:20210225T155956Z
CREATED:20201225T155643Z
LAST-MODIFIED:20210225T155956Z
UID:48627-1610467200-1610472600@globalbiodefense.com
SUMMARY:COVID-19 and Influenza & 1918 Influenza and COVID-19: A Tale of Two Pandemics
DESCRIPTION:A virtual presentation on “COVID-19 and Influenza & 1918 Influenza and COVID-19: A Tale of Two Pandemics” will be held on Jan 12\, 2021 as part of the 2021 Demystifying Medicine Series. \nThe 2021 Demystifying Medicine Series\, which is jointly sponsored by FAES and NIH\, will begin January 12 and includes the presentation of patients\, pathology\, diagnosis and therapy in the context of major disease problems and current research. Primarily directed toward Ph.D. students\, clinicians and program managers\, the course is designed to help bridge the gap between advances in biology and their application to major human diseases. Each session includes clinical and basic science components presented by NIH staff and invitees. All students\, fellows and staff are welcome\, as well. \nThe speakers for this virtual seminar are: \n\nAnthony Fauci\, MD (NIAID)\nJeffrey Taubenberger\, MD\, PhD (NIAID)\n\nPlease visit the NIH Demystifying Medicine website for more information.
URL:https://globalbiodefense.com/event/covid-19-and-influenza-1918-influenza-and-covid-19-a-tale-of-two-pandemics/
CATEGORIES:Government Hosted,Webinar-Webcast,Workshop
LOCATION:https://videocast.nih.gov/watch=41281
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201214
DTEND;VALUE=DATE:20201218
DTSTAMP:20200927T230726Z
CREATED:20200927T230726Z
LAST-MODIFIED:20200927T230726Z
UID:47223-1607904000-1608249599@globalbiodefense.com
SUMMARY:Brookhaven Laboratory Workshop for Industry Researchers
DESCRIPTION:Do you have an R&D challenge that you can’t solve with traditional commercial techniques? This specialized virtual workshop will offer access to unique x-ray\, electron and optical techniques\, which are designed for understanding materials in unprecedented ways. \nBrookhaven National Laboratory will host a virtual workshop on December 14-17\, 2020 for industry researchers to showcase the capabilities and expertise available at U.S. Department of Energy (DOE) Office of Science User Facilities located at Brookhaven Lab. \nThe workshop is designed to benefit both researchers who have previously used Brookhaven facilities for their work and those who are interested in learning about accessing them for the first time. \nThe workshop will inform researchers from industry about the leading-edge capabilities and expertise at Brookhaven facilities\, and provide details about the mechanisms for accessing them. The workshop will also more broadly introduce participants to DOE programs designed to support industry research. \nThe workshop agenda will feature presentations from industry users of Brookhaven Lab facilities\, question-and-answer sessions\, and opportunities to directly hear from Department of Energy program managers for your questions. \nHighlighted presentations include: \n\nBio and pharmaceuticals\nNanofabrication; Materials synthesis and characterization\nInnovative Chemistry through Advanced Microscopy Techniques\, Ke‐Bin Low\, BASF\nBio‐inspired invisible glass: from nature to commercialization\, Calvin Cheng\, Edgehog\nOverview of capabilities of NSLS‐II and CFN\, John Hill\, BNL\nX‐ray diffraction/scattering\nElectron microscopy\nHard and soft x‐ray spectroscopy\nAdvanced UV and x‐ray probes\nImaging and microscopy\nAdvanced optical spectroscopy and microscopy\nLessons learned as industry users of BNL facilities ‐‐ panel discussion\nDOE SBIR/STTR Program\, Manny Oliver\, SBIR/STTR Program Office\, DOE\nDOE TIR Program\, Eli Levine\, Advanced Manufacturing Office\, DOE\nDOE TCF Program\, Zack Baize\, Office of Technology Transitions\, DOE\nStrategic Partnership Program\, Ivar Strand\, BNL\nHelp desk and other DOE user facilities Q&A\nHow to become an industrial user and access facilities – Jun Wang (EPS)\nHow to write a good nonproprietary industrial proposal – Lisa Miller (NSLS‐II)\, Priscilla\nAntunez (CFN)\n\nThe workshop will provide a unique “facilities open house” format\, where attendees will spend time remotely in the labs observing Brookhaven’s capabilities in action and engaging in technical discussions with Brookhaven experts. The workshop will also provide an opportunity for attendees to remotely measure their own samples\, collecting meaningful data to take home that day. \nLearn more
URL:https://globalbiodefense.com/event/brookhaven-laboratory-workshop-for-industry-researchers/
LOCATION:Brookhaven Lab – Berkner Hall\, Lewis Road\, Upton\, 11973\, United States
CATEGORIES:Government Hosted,Industry Day,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/09/brookhaven-national-lab-doe-science-user-facilities-industry-researchers-event.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201109
DTEND;VALUE=DATE:20201111
DTSTAMP:20201108T212120Z
CREATED:20201101T211658Z
LAST-MODIFIED:20201108T212120Z
UID:47853-1604880000-1605052799@globalbiodefense.com
SUMMARY:Aberdeen Proving Ground Virtual Career Fair
DESCRIPTION:Organizations across Aberdeen Proving Ground will accept resumes during the installation’s first virtual career fair November 9 and 10\, 2020. \nThe virtual hiring event\, hosted by the U.S. Army Communications-Electronics Command\, will provide opportunities for applicants to submit their resumes and other information through an online\, mobile recruiting application. \n“We are excited for our first ever virtual job fair for the APG community\,” said CECOM Human Resources Specialist Steve Faulkner. “COVID-19 has forced us all into being more innovative in our approach in human resources\, particularly in recruiting.” \nIn an effort to practice social distancing\, about half a dozen APG organizations and subordinate commands will use the virtual event to recruit candidates for a variety of career fields in multiple locations. For career opportunities in information technology\, law enforcement\, engineering\, financial management\, logistics\, communications\, just to name a few\, applicants will apply for positions from the safety of their personal computers and mobile devices. \nAPG – Career Fair\nAPG is relying on its social media channels to promote hiring opportunities\, and to engage potential candidates. Job seekers are encouraged to ask questions and share the event information with friends\, to ensure high visibility and maximum participation. \n“To meet the mission\, hiring organizations must continue to hire the best qualified employees\,” Faulkner said. “We have opportunities at APG; Tobyhanna\, Pennsylvania; Fort Detrick\, Maryland; Fort Huachuca\, Arizona; Fort Belvoir\, Virginia\, and many more locations.” \nSome of the participating organizations include CECOM\, the Army 20th CBRNE Command\, APG Garrison\, Army Futures Command organizations\, Army Medical Research Institute of Chemical Defense (USAMRICD)\, Army Program Executive Office – Command\, Control and Communications Tactical and many more. \nThe APG workforce has more than 21\,000 military\, civilian and contractor employees responsible for numerous technical achievements across a broad spectrum of military capabilities. If a Soldier uses a piece of technology for protection\, intelligence\, shooting\, movement or to communicate\, chances are it was developed\, tested and fielded by an APG organization. \nThe APG Virtual Career Fair event page on Facebook includes information on hiring organizations and how to submit resumes. Learn more: https://www.facebook.com/events/354326535799511
URL:https://globalbiodefense.com/event/aberdeen-proving-ground-virtual-career-fair/
CATEGORIES:Government Hosted,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/11/apg-usamricd-virtual-career-fair.jpg
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201104T121500
DTEND;TZID=America/New_York:20201104T131500
DTSTAMP:20201103T012824Z
CREATED:20201003T002424Z
LAST-MODIFIED:20201103T012824Z
UID:47785-1604492100-1604495700@globalbiodefense.com
SUMMARY:FDA Virtual Town Hall Series - COVID-19 Test Development and Validation
DESCRIPTION:The U.S. Food and Drug Administration (FDA) will host a virtual Town Hall for SARS-CoV-2 test developers 4 Nov 2020 from 12:15 PM – 1:15 PM Eastern. \nThe FDA plays a critical role in protecting the United States from threats such as emerging infectious diseases\, including the Coronavirus Disease 2019 (COVID-19) pandemic. The FDA is committed to providing timely guidance to support response efforts to this pandemic. \nThe immediately in effect guidance “Policy for Coronavirus Disease-2019 Tests During the Public Health Emergency (Revised)” includes policies specific to this public health emergency. This guidance was issued on February 29\, 2020 and subsequently updated on March 16\, 2020\, May 4\, 2020\, and May 11\, 2020. \nThe FDA will also hold virtual Town Halls for test developers to help answer questions on: \n\nNovember 18\, 2020 from 12:15 pm – 1:15 pm Eastern Time\nDecember 2\, 2020 from 12:15 pm – 1:15 pm Eastern Time\nDecember 9\, 2020 from 12:15 pm – 1:15 pm Eastern Time\nDecember 16\, 2020 from 12:15 pm – 1:15 pm Eastern Time\n\nLearn more
URL:https://globalbiodefense.com/event/fda-virtual-town-hall-series-covid-19-test-development-and-validation/
CATEGORIES:Government Hosted,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201028T113000
DTEND;TZID=America/New_York:20201028T153000
DTSTAMP:20201024T215523Z
CREATED:20201024T215523Z
LAST-MODIFIED:20201024T215523Z
UID:47656-1603884600-1603899000@globalbiodefense.com
SUMMARY:National Virtual Biotechnology Laboratory Symposium
DESCRIPTION:The National Virtual Biotechnology Laboratory Symposium will be held Oct. 28\, 2020. \nThis online event will highlight the impact the U.S. Department of Energy’s (DOE) National Virtual Biotechnology Laboratory has had utilizing the unique capabilities of the DOE to tackle the science and technology challenges associated with COVID-19\, and to discuss areas in which the National Virtual Biotechnology Laboratory can have impact in the future. \nSPEAKERS \n\nOverview of Science & Technology Challenges for COVID – NVBL Co-Leads Michelle Buchanan\, Oak Ridge National Laboratory\, and Stephen Streiffer\, Argonne National Laboratory\nFuture S&T Needs: Future of Testing & Surveillance – Bruce Tromberg\, Director\, National Institute of Biomedical Imaging & Bioengineering\, National Institutes of Health\nFuture S&T Needs: AI/ML and Computing – Jim Brase\, Deputy Associate Director for Computation\, Lawrence Livermore National Laboratory\nFuture S&T Needs: Vaccines – Greg Burel\, President\, Hamilton Grace\, LLC\nClosing Remarks – Harriet Kung\, Deputy Director for Science\, DOE Office of Science\n\nThe U.S. Department of Energy National Virtual Biotechnology Laboratory (NVBL) is a consortium of DOE National laboratories\, each with core capabilities relevant to the threats posed by COVID-19. The NVBL is taking advantage of DOE user facilities\, including light and neutron sources\, nanoscale science centers\, sequencing and bio-characterization facilities\, and high performance computer facilities\, to address key challenges in responding to the COVID-19 threat.  Examples include developing innovations in testing capabilities\, identifying new targets for medical therapeutics\, providing epidemiological and logistical support\, and addressing supply chain bottlenecks by harnessing extensive additive manufacturing capabilities.  The NVBL collaborates extensively with researchers\, both in academia and the private sector.  In addition\, the DOE user facilities are available to users in all sectors of the research community. \nRegister in advance for this webinar event.
URL:https://globalbiodefense.com/event/national-virtual-biotechnology-laboratory-symposium/
CATEGORIES:Government Hosted,Webinar-Webcast
LOCATION:https://www.zoomgov.com/webinar/register/WN_1nEkc3YYR2ODU-W0ZzODlA
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201027
DTEND;VALUE=DATE:20201031
DTSTAMP:20200922T181413Z
CREATED:20200922T181413Z
LAST-MODIFIED:20200922T181413Z
UID:47146-1603756800-1604102399@globalbiodefense.com
SUMMARY:NIH Program Funding and Grants Administration Virtual Seminar
DESCRIPTION:The National Institutes of Health invites you to take part in a unique opportunity to learn more about\nworking with the NIH grants process\, programs\, policies\, and staff at the 2020 NIH Virtual Seminar on Grants Administration and Program Funding 27-30 October 2020. \nThis seminar is designed for those who are new to working with the NIH grants process – administrators\, early stage investigators\, researchers\, graduate students\, etc. For those with more experience\, NIH experts provide a few sessions that are designed for participants that are more advanced and are focused on more in-depth polices and processes. \nWhat to expect?\nYou may be familiar with the NIH Regional Seminar and wondering if this is the same event moved to a virtual environment. There are some similarities\, but also some modifications to accommodate the new format. \n\nThis event is scheduled over four days in the afternoons only (U.S. New York time zone – EDT). Sessions 1:00 PM – 5:45 PM\nThere are three tracks of sessions which are open to any participants on any given day without any further registration.\nAll sessions are 45-minute sessions with a 15 minute break before the next session begins. Some are live\, while others are simulive (a combination of a pre-recorded video and live Q&A).\nRepresentatives from NIH programs\, offices\, and Institutes and Centers will be presenting and attending booths in the Meet the Experts Exhibit Hall.\nThe seminar is free!\n\nTuesday\, October 27 – Thursday\, October 29 \n\n\nTrack 1\nNIH Grant Process \n\n\nLooking for an overview of the NIH Grant Process from application preparation to post-award management? This is the track for you! \n\n\n\n\nTrack 2\nNIH Grant Policies & Programs \n\n\nWanting to learn about specific programs offered by NIH or receive updates on the latest NIH & HHS policies? Check out this track. \n\n\n\n\nTrack 3\nLet’s Talk About It \n\n\nSessions in this track are designed to be more interactive with Question & Answer sessions and case studies. \n\n\nFriday\, October 30 \nTracks are slightly different with sessions that are primarily focused on a general topic or program: \n\n\nSpecial Focus 1:\nHuman Subjects in Research \n\n\nIf your research meets the definition of involving human subjects\, then you’ll want to participate in these sessions provided by OHRP and NIH. \n\n\n\n\nSpecial Focus 2:\nSEEDing the Marketplace \n\n\nThe NIH SEED (Small business Entrepreneurial Education) team is providing a track focused on developing relationships and building relationshops for innovators to move towards production. \n\n\n\n\nTrack 3\nLet’s Talk About It \n\n\nVisit this track for sessions focused on business\, inventions\, and data. Visit for more interactive with Q&A and/or case studies. \n\n\nWho are the Presenters?\nThis seminar involves over 50 NIH and HHS presenters and over 100 additional experts at the NIH booths who are eager to educate\, share\, and hear your questions during this event. It’s your opportunity to interact with NIH policy officials\, grants management\, program and review staff\, and representatives from the HHS Office for Human Research Protections (OHRP) and HHS Office of Research Integrity. Select the “Presenters” tab to see a selection of NIH & HHS experts who will be providing presentations. \nView the full AGENDA \nRegister HERE.
URL:https://globalbiodefense.com/event/nih-program-funding-and-grants-administration-virtual-seminar/
CATEGORIES:Government Hosted,Webinar-Webcast,Workshop
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201027
DTEND;VALUE=DATE:20201028
DTSTAMP:20200927T165438Z
CREATED:20200802T163328Z
LAST-MODIFIED:20200927T165438Z
UID:47192-1603756800-1603843199@globalbiodefense.com
SUMMARY:BARDA Industry Day 2020
DESCRIPTION:The Biomedical Advanced Research and Development Authority (BARDA) will host a virtual Industry Day on October 27\, 2020 to learn about U.S. Government medical countermeasure priorities\, interact with the BARDA and HHS ASPR teams\, and network with public and private sector colleagues. \nFeatured speakers and breakout presenters will address the many ways BARDA is actively addressing the current COVID-19 pandemic crisis and forging new partnerships while remaining vigilant and prepared for any new threats that may arise. \nBARDA Industry Day 2020 will include breakout sessions\, virtual networking opportunities\, and an address by Acting BARDA Director\, Dr. Gary Disbrow. Lightning Talk sessions will be available to selected applicants\, which provide an opportunity to present their technologies to an audience of BARDA specialists\, industry partners\, and potential collaborators. \nThe conference is open to anyone in the public who wishes to attend. The content is mainly geared towards healthcare research professionals and medical countermeasure developers\, government agency staff\, pharmaceutical professionals\, and scientific researchers and academics. \nThe breakout sessions and plenary discussions will be available for viewing on the conference website after the event \nLearn more: http://bit.ly/bardaindustryday2020 \nEditor’s Update 31 Aug: The Lightning Talks application submission period is now closed. Event registration is still open.
URL:https://globalbiodefense.com/event/barda-industry-day-2020/
CATEGORIES:Government Hosted,Industry Day,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/09/barda-industry-day-2020.jpg
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201022T100000
DTEND;TZID=America/New_York:20201022T170000
DTSTAMP:20200927T172033Z
CREATED:20200927T172033Z
LAST-MODIFIED:20200927T172033Z
UID:47197-1603360800-1603386000@globalbiodefense.com
SUMMARY:FDA Vaccines and Related Biological Products Advisory Committee Meeting
DESCRIPTION:On October 22\, 2020\, the Center for Biologics Evaluation and Research’s (CBER)\, Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet in open session\, to discuss\, in general\, the development\, authorization and/or licensure of vaccines to prevent COVID-19. No specific application will be discussed at this meeting. \nFDA intends to make background material available to the public no later than 2 business days before the meeting. If FDA is unable to post the background material on its website prior to the meeting\, any background material will be made publicly available at the time of the advisory committee meeting\, and additional materials will be posted on FDA’s website after the meeting. \nMaterials for this meeting will be available at the Vaccines and Related Biological Products Advisory Committee meetings main page. \nThe meeting will include slide presentations with audio components to allow the presentation of materials in a manner that most closely resembles an in-person advisory committee meeting. \nPublic Participation Information\nInterested persons may present data\, information\, or views\, orally or in writing\, on issues pending before the committee. \n\nWritten submissions may be made to the contact person on or before October 15\, 2020.\nOn October 22\, 2020\, oral presentations from the public will be scheduled between approximately 2:30 p.m. and 3:30 p.m. EST.\n\nThose individuals interested in making formal oral presentations should notify the contact person and submit a brief statement of the general nature of the evidence or arguments they wish to present\, the names and addresses of proposed participants\, and an indication of the approximate time requested to make their presentation on or before October 7\, 2020. Time allotted for each presentation may be limited. If the number of registrants requesting to speak is greater than can be reasonably accommodated during the scheduled open public hearing session\, FDA may conduct a lottery to determine the speakers for the scheduled open public hearing session. The contact person will notify interested persons regarding their request to speak by October 8\, 2020. \nWebcast Information\nCBER plans to provide a free of charge\, live webcast of the Vaccines and Related Biological Products Advisory Committee meeting. If there are instances where the webcast transmission is not successful; staff will work to re-establish the transmission as soon as possible. \nThe online web conference meeting will be available at:\nhttp://fda.yorkcast.com/webcast/Play/c26e83a0f77a412296949f4f43af4c981d
URL:https://globalbiodefense.com/event/fda-vaccines-and-related-biological-products-advisory-committee-meeting/
CATEGORIES:Government Hosted,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20201021T090000
DTEND;TZID=America/Los_Angeles:20201021T160000
DTSTAMP:20200922T215239Z
CREATED:20200922T215225Z
LAST-MODIFIED:20200922T215239Z
UID:47162-1603270800-1603296000@globalbiodefense.com
SUMMARY:Innovations in Health Metrics Sciences: Measuring\, Mapping\, and Monitoring Morbidity and Mortality at the Regional\, National\, and Local Levels in Africa
DESCRIPTION:The National Institutes of Health will host a virtual learning session entitled ‘Innovations in Health Metrics Sciences: Measuring\, Mapping\, and Monitoring Morbidity and Mortality at the Regional\, National\, and Local Levels in Africa‘ on 21 October 2020 as part of the DS-I Africa Virtual Forum series. \nThis session will highlight the emerging field of health metrics sciences and its role in measuring and monitoring summary measures of health in Africa to better develop and implement measures to reduce the burden of disease. Identify challenges and opportunities relevant to the DS-I Africa initiatives. Address the increasing role that health metrics is playing in informing and prioritizing systems-level health interventions and broad public health-related decision making. Discuss how health metrics and data science can inform and evaluate more effective integrated care efforts at the intersection of infectious diseases and the rapidly growing burden of chronic\, non-communicable diseases \nModerator:\nKaren Sliwa\, University of Cape Town \nPanelists:\nMayowa Ojo Owolabi\, University of Ibadan \nDebbie Bradshaw\, South African Medical Research Council \nAna Olga H Mocumbi\, Mondlane University \nAli H. Mokdad\, Institute for Health Metrics and Evaluation \nTo participate in the discussion and session\, you must register for the DS-I Africa Virtual Forum in advance. All content will also be recorded and posted on this website after each event.
URL:https://globalbiodefense.com/event/innovations-in-health-metrics-sciences-measuring-mapping-and-monitoring-morbidity-and-mortality-at-the-regional-national-and-local-levels-in-africa/
CATEGORIES:Government Hosted,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201014T090000
DTEND;TZID=America/New_York:20201014T160000
DTSTAMP:20200922T214817Z
CREATED:20200922T214735Z
LAST-MODIFIED:20200922T214817Z
UID:47160-1602666000-1602691200@globalbiodefense.com
SUMMARY:Using Data Science to Fight COVID-19
DESCRIPTION:The National Institutes of Health will host a virtual learning session entitled ‘Using Data Science to Fight COVID-19‘ on 14 October 2020 as part of the DS-I Africa Virtual Forum series. \nModerator:\nStefan Jaeger\, National Library of Medicine\, National Institutes of Health \nPanelists:\nAgnes Kiragga\, Ph.D.\, Head of Statistics and Data Management Unit and Senior Research Scientist\, Infectious Diseases Institute (IDI)\, Makerere University College of Health Sciences \nNirmal Ravi\, MD\, Ph.D. \nAli H. Mokdad\, Ph.D.\, Professor of Health Metrics Sciences\, the Institute for Health Metrics and Evaluation; Chief Strategy Officer\, Population Health at the University of Washington \nElaine Nsoesie\, Ph.D.\, Assistant Professor of Global Health\, Boston University School of Public Health \nFrank Kagoro\, Ph.D.\, Research Physician\, MORU Tropical Health Network and WorldWide Antimalarial Resistance Network \nTo participate in the discussion and session\, you must register for the DS-I Africa Virtual Forum in advance. All content will also be recorded and posted on this website after each event.
URL:https://globalbiodefense.com/event/using-data-science-to-fight-covid-19/
CATEGORIES:Government Hosted,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201007T090000
DTEND;TZID=America/New_York:20201007T160000
DTSTAMP:20200922T214447Z
CREATED:20200922T214447Z
LAST-MODIFIED:20200922T214447Z
UID:47158-1602061200-1602086400@globalbiodefense.com
SUMMARY:Innovative Approaches to Improve Maternal and Child Health
DESCRIPTION:The National Institutes of Health will host a virtual learning session entitled ‘Innovative Approaches to Improve Maternal and Child Health‘ on 7 October 2020 as part of the DS-I Africa Virtual Forum series. \nMaternal and child health outcomes in Africa still lag behind the rest of the world despite prioritization as a topic of focus within the United Nations Sustainable Development Goals (SDGs). Partners from  country-level governments\, research institutions\, private sector program funding agencies and non-governmental organizations are involved in various capacities and across disciplines\, implementing activities to reduce the enormous burden of high mortality and morbidity of women and children on the African continent.  Nonetheless\, millions of women and children experience death and severe morbidity each year despite these efforts. In this session we will 1) address the gap in availability of existing databases and collective data focused on pregnancy and the peripartum period; 2) explore emerging use of linked data such as electronic medical records as a tool for conducting research\, analyzing data and creating tools for interventions; and 3) develop concrete recommendations for a strategy to utilize data science to improve maternal and child health outcomes from pre-pregnancy to pregnancy and delivery and throughout the mother and child’s life course. \nIntroductions:\nVesna Kutlesic\, US Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)\, National Institutes of Health (NIH) \nDiana Bianchi\, Director of NICHD\, NIH \nNaveen Rao\, MD\, Senior Vice President & Senior Advisor to the President\, Health Initiative\, The Rockefeller Foundation \nModerator:\nDenise Russo\, NICHD\, NIH \nPanelists:\nAndre van der Kouwe\, Ph.D.\, Associate Professor in Radiology\, Harvard Medical School\, Assistant in Physics\, Massachusetts General Hospital \nLilla Zöllei\, Ph.D.\, Assistant Professor of Radiology\, Harvard Medical School \nMoses Alobo\, M.D.\, Program Manager\, Grand Challenges Africa Programme at African Academy of Sciences \nAlash’le Abimiku\, Ph.D.\, Professor in Epidemiology & Public Health\, University of Maryland School of Medicine; Executive Director\, International Research Center of Excellence at the Institute of Human Virology-Nigeria \nAmel Ghouila\, Ph.D.\, Bioinformatician\, Capacity Builder\, Pan African Bioinformatics \nTo participate in the discussion and session\, you must register for this DS-I Africa Virtual Forum in advance. All content will also be recorded and posted on this website after each event.
URL:https://globalbiodefense.com/event/innovative-approaches-to-improve-maternal-and-child-health/
CATEGORIES:Government Hosted,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200930T130000
DTEND;TZID=America/New_York:20200930T143000
DTSTAMP:20200927T191940Z
CREATED:20200827T174326Z
LAST-MODIFIED:20200927T191940Z
UID:47213-1601470800-1601476200@globalbiodefense.com
SUMMARY:DTRA Chemical and Biological Technologies Department: Student Workforce Opportunities
DESCRIPTION:The Defense Threat Reduction Agency’s Chemical and Biological Technologies Department (DTRA-CB) will host a University Engagement Webinar: Student Workforce Opportunities on Wednesday\, Sept. 30\, 2020. \nDuring this webinar\, participants will learn about internships\, scholarships\, fellowships\, postdoctoral and employment opportunities available through the DoD and federal government. \nTopics that will be discussed include: \n\nMore on DTRA-CB’s role as the DoD’s Joint Science and Technology Office for Chemical and Biological Defense (JSTO-CBD)\nNational Research Council (NRC) Research Associateship (Postdoctoral) Program\nPathways Programs: Pathways Internship Programs\, Recent Graduates Program and the Presidential Management Fellows Program (PMF)\nNavigating USAJOBS for employment opportunities\nScience\, Mathematics\, and Research for Transformation (SMART) Scholarship-for-Service Program benefits\, application deadlines and success stories\n\nLearn more: http://bit.ly/dtracbd-student-workforce
URL:https://globalbiodefense.com/event/dtra-chemical-and-biological-technologies-department-student-workforce-opportunities/
CATEGORIES:Government Hosted,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/08/defense-threat-reduction-chemical-biological-defense-dtra-cbd-jsto-university-engagement-global-biodefense.jpg
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200930T090000
DTEND;TZID=America/New_York:20200930T160000
DTSTAMP:20200922T212454Z
CREATED:20200922T212454Z
LAST-MODIFIED:20200922T212454Z
UID:47156-1601456400-1601481600@globalbiodefense.com
SUMMARY:Biomedical Informatics and Data Sciences in Africa
DESCRIPTION:The National Institutes of Health will host a virtual learning session entitled ‘Biomedical Informatics and Data Sciences in Africa‘ on 30 September 2020 as part of the DS-I Africa Virtual Forum series. \nThis session will address emerging opportunities and challenges in the application of Data Science and Informatics technologies in various biomedical domains. It will also highlight some key challenges in the areas of data mining\, data quality\, standards for various types of data\, in addition to addressing how cutting-edge data analytics\, predictive modeling and Machine Learning\, and methods for simulations can advance human health in Africa. \nModerator: \nDarrell Hurt\, National Institute of Allergy and Infectious Diseases\, National Institutes of Health (NIH) \nGeetha Senthil\, National Institute of Mental Health\, NIH\nPanelists:\nAgnes Abdoulaye Banire Diallo\, University of Quebec-Montreal (UQAM) \nElaine Nsoesie\, Boston University \nGeoffrey Siwo\, University of Notre Dame \nDina Machuve\, Nelson Mandela African Institution of Science and Technology \nMoustapha Cisse\, Google AI \nTo participate in the discussion and session\, you must register for the DS-I Africa Virtual Forum in advance. All content will also be recorded and posted on this website after each event.
URL:https://globalbiodefense.com/event/biomedical-informatics-and-data-sciences-in-africa/
CATEGORIES:Government Hosted,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200924T130000
DTEND;TZID=America/New_York:20200924T143000
DTSTAMP:20200922T011528Z
CREATED:20200919T010636Z
LAST-MODIFIED:20200922T011528Z
UID:47130-1600952400-1600957800@globalbiodefense.com
SUMMARY:Clearing the Path: Responding to Disasters During a Crisis
DESCRIPTION:The Department of Homeland Security (DHS) Science and Technology Directorate (S&T) is convening a diverse group of public-private partners to present\, Clearing the Path: Responding to Disasters During a Crisis\, a virtual discussion for National Preparedness Month\, on September 24\, 2020\, from 1:00 p.m. – 2:30 p.m. EST. \nWhen responding to natural disasters during a crisis\, such as the COVID-19 pandemic\, emergency responders\, hospitals\, and supply chains are working at capacity\, while the next hurricane\, wildfire\, or flood could be around the corner. For communities to adapt and respond to these compounding pressures\, they must understand how technologies can inform risk-based decision making in areas of neighborhood health monitoring\, supply chains\, evacuation planning\, crisis communications\, and information sharing among front-line responders. Innovation in predictive analytics\, modeling and simulation\, and mobility offer new solutions to tackle immediate challenges and prepare for emerging threats. \nTopics of this virtual discussion will include: \n\nUnderstanding how public-private partnerships are accelerating new solutions and business models to prepare for day-to-day emergencies and a national crisis.\nEducating community leaders on how new science and technology applications are enhancing resilience and protecting life-line systems and networks.\nWith increased frequency of new threats\, examining what new tools and policies are available to incentivize collaboration among government\, industry\, and foundations.\nWith communities investing in automated and digital technologies\, asking why this is important and how predictive data sets are changing the way we think about risk and preparedness.\n\nSpeakers include: \n\nDavid Maurstad\, Deputy Associate Administrator\, FEMA\n\n\nDuane Caneva\, Chief Medical Officer\, DHS Countering WMD Office\n\n\nTed Smith\, Ph.D.\, Wastewater Based Epidemiology\, Professor of Environmental Medicine\, University of Louisville and Advisor to Louisville Mayor\, Greg Fischer\n\n\nCatherine Cross\, Deputy Under Secretary\, DHS Science and Technology Directorate (S&T)\n\n\nDavid Corman\, Program Director\, Cyber-Physical Systems and Smart and Connected Communities\, National Science Foundation\n\n\nRichard Seline\, Executive Director\, Accelerate H2O\, Houston\, TX\n\n\nMichel Leonard\, Vice President and Senior Economist\, Insurance Information Institute\n\n\nModerator: David Alexander\, Director of Resilience Research and Partnerships\, DHS S&T\n\nTo register for the National Preparedness Month Virtual Discussion: Clearing the Path: Responding to Disasters During a Crisis\, please register here.
URL:https://globalbiodefense.com/event/clearing-the-path-responding-to-disasters-during-a-crisis/
CATEGORIES:Government Hosted,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/09/national-preparedness-clearing-path-disaster-crisis-response-dhs.jpg
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200923T090000
DTEND;TZID=America/New_York:20200923T160000
DTSTAMP:20200922T212137Z
CREATED:20200822T211622Z
LAST-MODIFIED:20200922T212137Z
UID:47153-1600851600-1600876800@globalbiodefense.com
SUMMARY:Leveraging Data Science Approaches to Address Environmental Health Challenges in Africa
DESCRIPTION:Environmental Health challenges in Africa are complex\, involving a broad range of exposures\, including ambient and indoor air pollution\, electronic waste\, heavy metals\, pesticides\, vector-borne pathogens\, and climate change\, and a large proportion of the disease burden in Africa is linked to environmental factors. This session will explore unique aspects and analytic challenges of the various types of environmental health data and will highlight recent data science approaches to characterizing hazardous exposures on the African continent\, connecting environmental exposures to health outcomes\, and reducing the risk of disease connected to the environment. \nModerator:\nGwen Collman\, Acting Deputy Director\, Associate Director for Extramural Research\, National Institute of Environmental Health Sciences \nPanelists:\nKiros Berhane\, Professor and Chair\, Department of Biostatistics\, Mailman School of Public Health\, Columbia University \nCaradee Wright\, Senior Specialist Scientist\, Environment and Health Research Unit\, South African Medical Research Council \nEngineer Bainomugisha\, Associate Professor and Chair\, Department of Computer Science\, School of Computing & IT\, Makerere University \nTo participate in the discussion and session\, you must register for the DS-I Africa Virtual Forum in advance. All content will also be recorded and posted on this website after each event.
URL:https://globalbiodefense.com/event/leveraging-data-science-approaches-to-address-environmental-health-challenges-in-africa/
CATEGORIES:Government Hosted,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200609
DTEND;VALUE=DATE:20200611
DTSTAMP:20200609T170801Z
CREATED:20200527T162939Z
LAST-MODIFIED:20200609T170801Z
UID:46303-1591660800-1591833599@globalbiodefense.com
SUMMARY:APG Advance Planning Briefing to Industry 2020
DESCRIPTION:The Aberdeen Proving Ground (APG) Advance Planning Briefing to Industry (APBI) and Technological Expo\, will be held virtually on 9-10 June 2020\, in lieu of being hosted live at APG\, MD. \nThe goal of the APG APBI is to provide industry with networking opportunities for both large and small businesses. The APBI will describe potential future contracting opportunities for mission areas that focus on: \n\nChemical and Biological Defense\nCommand\, Control\, Communications\, Computers\, Cyber\, Intelligence\, Surveillance\, and Reconnaissance\nResearch and Development\nTest and Evaluation\nAPG Garrison\n\nThe APG APBI will identify potential contracting opportunities that are aligned with the roadmaps of each respective organization\, specifically focusing on Fiscal Years 2021–2022. The Government will not hear formal bids from industry\, as the purpose of the APBI is for the Government to brief upcoming opportunities to industry to help it better understand Army capability requirements and shape its internal development efforts. \nDAY ONE \n0730–0830 Microsoft Teams Setup\n0830–0845 Welcome Remarks by MG Kilgo\n0850–0950 Army Contracting Command-Aberdeen Proving Ground\n0955–1125 Army Contracting Command-Aberdeen Proving Ground: Role of Division Chiefs\n1130–1245 Communications-Electronics Command Defense Logistics Agency-Aberdeen Proving Ground\n1330–1445 Program Executive Office Command Control Communications-Tactical & Network Cross-Functional Team\n1450–1520 Joint Program Executive Office for Chemical\, Biological\, Radiological and Nuclear Defense  Click to download slides for JPEO-CBRND presentation \nDAY TWO \n0730–0830 Microsoft Teams Setup\n0830–0930 Program Executive Office for Intelligence\, Electronic Warfare & Sensors\n0935–1005 Program Executive Office for Intelligence\, Electronic Warfare & Sensors: C5 OTA Consortium Overview\n1010–1040 Program Executive Office for Intelligence\, Electronic Warfare & Sensors: Multi-Domain Sensing System Contract Strategy Overview\n1045–1115 Program Executive Office for Intelligence\, Electronic Warfare & Sensors: PM\, Electronic Warfare & Cyber 21 Strategic Planning Guidance\n1120–1150 Combat Capabilities Development Command\n1155–1225 Combat Capabilities Development Command-CMOSS\n1230–1300 Army Test and Evaulation Command\n1305–1335 A Message from the Office of Small Business Programs\n1340–1410 APG Garrison\n1415–1445 Closing Remarks by MG Kilgo \nThe APG APBI will be unclassified and open to all interested contractors\, large and small businesses\, and academia\, as well as other Government stakeholders. There is no registration required for this event. \nIf you or your company has already purchased a ticket for APBI or reserved a table for the 2020 Team APG Tech Expo\, please contact MissionTix directly for a refund. MissionTix contact information is: 888-996-4774 or help@missiontix.com.
URL:https://globalbiodefense.com/event/apg-advance-planning-briefing-to-industry-2020/
LOCATION:Virtual-Webcast
CATEGORIES:Conference,Government Hosted,Industry Day,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/06/apg-abpi-cbrne-2020.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200303
DTEND;VALUE=DATE:20200306
DTSTAMP:20191227T222008Z
CREATED:20191115T214342Z
LAST-MODIFIED:20191227T222008Z
UID:36020-1583193600-1583452799@globalbiodefense.com
SUMMARY:Mitigating the Impact of Blast-related Burn Injuries: From Prolonged Field Care to Rehabilitation and Resilience
DESCRIPTION:The 9th DoD State-of-the-Science Meeting on Blast Injury Research will be held March 3-5\, 2020 in Arlington\, Virginia. \nThe meeting will address epidemiology and outcomes of blast-related burn injuries; prevention and acute management of blast-related burn injuries; prolonged field care and chronic care; and transforming research. \nThis meeting is sponsored by the DoD Blast Injury Research Coordinating Office\, U.S. Army Medical Research and Development Command\, on behalf of the DoD Executive Agent for Medical Research for Prevention\, Mitigation\, and Treatment of Blast Injuries. \nThe event is presented by the RAND National Security Research Division (NSRD)\, which conducts research and analysis for all national security sponsors other than the U.S. Air Force and the Army. The division includes the National Defense Research Institute\, a federally funded research and development center whose sponsors include the Office of the Secretary of Defense\, the Joint Staff\, the Unified Combatant Commands\, the defense agencies\, and the Department of the Navy. NSRD also conducts research for the U.S. intelligence community and the ministries of defense of U.S. allies and partners. \nThis will be a working meeting. Over 100 subject matter experts from the DoD\, other Federal agencies\, academia\, industry\, and the international community are expected to participate. \nAttendance is free\, first come-first serve\, and capped at 150. There are no continuing education credits\, and participants are responsible for their own travel\, lodging\, and expenses. \nEDITOR’S UPDATE: Registration for the Ninth State-of-the-Science Meeting is now full. If you would like to be added to the waitlist\, contact the event organizers here.
URL:https://globalbiodefense.com/event/mitigating-the-impact-of-blast-related-burn-injuries-from-prolonged-field-care-to-rehabilitation-and-resilience/
LOCATION:RAND’s Pentagon City Office\, 4th Floor\, 1200 South Hayes Street\, Arlington\, VA\, 22202-5050\, United States
CATEGORIES:Conference,Government Hosted
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200227T140000
DTEND;TZID=America/New_York:20200227T160000
DTSTAMP:20200220T230510Z
CREATED:20200220T225626Z
LAST-MODIFIED:20200220T230510Z
UID:40056-1582812000-1582819200@globalbiodefense.com
SUMMARY:Coronavirus Disease 2019: The U.S. and International Response
DESCRIPTION:The House Foreign Affairs Subcommittee on Asia\, the Pacific\, and Nonproliferation will hold a second subcommittee hearing on the coronavirus outbreak on 27 Feb 2020 at 2:00 Eastern. \nWitnesses will include U.S. government officials who have led the response to the virus. \nDate: Thursday\, February 27\, 2020 \nTime: 2:00 p.m. EST \nSubject: Coronavirus Disease 2019: The U.S. and International Response \nWitnesses: \n\nMr. Ian Brownlee\nPrincipal Deputy Assistant Secretary\, Bureau of Consular Affairs\, U.S. Department of State \nMr. Jonathan Fritz\nDeputy Assistant Secretary\, Bureau of East Asian and Pacific Affairs\, U.S. Department of State \nWilliam A. Walters\, Ph.D.\nExecutive Director and Managing Director for Operational Medicine\, Bureau of Medical Services\, U.S. Department of State \nRobert Redfield\, Ph.D.\nDirector\, U.S. Centers for Disease Control and Prevention
URL:https://globalbiodefense.com/event/coronavirus-disease-2019-the-u-s-and-international-response/
LOCATION:Rayburn House Office Building\, Washington\, DC\, United States
CATEGORIES:Conference,Government Hosted,Policy-Legislative
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200219T150000
DTEND;TZID=America/New_York:20200219T160000
DTSTAMP:20200208T165510Z
CREATED:20200208T165105Z
LAST-MODIFIED:20200208T165510Z
UID:39162-1582124400-1582128000@globalbiodefense.com
SUMMARY:Public Health Emergency Preparedness (PHEP) Monthly Call
DESCRIPTION:PHEP Recipient Monthly Conference Call Scheduled for February 19 \nCDC’s next monthly conference call with PHEP recipients will be held from 3 p.m. to 4 p.m. EDT on Wednesday\, February 19. Participant information is provided below. \n  \nConference Call Information \nBridge Line: (888) 566-1873 \nParticipant Code: 3358383 \n  \nThe Public Health Emergency Preparedness (PHEP) cooperative agreement is a critical source of funding for state\, local\, and territorial public health departments. Since 2002\, the PHEP cooperative agreement has provided assistance to public health departments across the nation. This helps health departments build and strengthen their abilities to effectively respond to a range of public health threats\, including infectious diseases\, natural disasters\, and biological\, chemical\, nuclear\, and radiological events. Preparedness activities funded by the PHEP cooperative agreement specifically targeted the development of emergency-ready public health departments that are flexible and adaptable.
URL:https://globalbiodefense.com/event/public-health-emergency-preparedness-phep-monthly-call/
CATEGORIES:Government Hosted,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200212T090000
DTEND;TZID=America/New_York:20200212T113000
DTSTAMP:20200206T212739Z
CREATED:20200204T172100Z
LAST-MODIFIED:20200206T212739Z
UID:38776-1581498000-1581507000@globalbiodefense.com
SUMMARY:Homeland Security & Governmental Affairs Committee: Protecting the U.S. from Global Pandemics
DESCRIPTION:The U.S. Senate Committee on Homeland Security & Governemental Affairs will convene a Full Committee hearing on Feb.12 to examine protecting the United States from global pandemics. \nROUNDTABLE: Are We Prepared? Protecting the U.S. from Global Pandemics will\nFebruary 12\, 2020 09:30 AM \nLocation: SD-G50\, Dirksen Senate Office Building \nThe meeting will air on CSPAN. \nSee also: Johnson\, Peters Ask DHS for Strategy for Containing the Coronavirus
URL:https://globalbiodefense.com/event/homeland-security-governmental-affairs-committee-protecting-the-u-s-from-global-pandemics/
LOCATION:Dirksen Senate Office Building\, Washington\, DC\, United States
CATEGORIES:Government Hosted,Policy-Legislative
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200210T140000
DTEND;TZID=America/New_York:20200210T150000
DTSTAMP:20200126T190837Z
CREATED:20200126T190718Z
LAST-MODIFIED:20200126T190837Z
UID:37779-1581343200-1581346800@globalbiodefense.com
SUMMARY:CDC National Call Series on Novel Coronavirus Monitoring & Preparedness
DESCRIPTION:The Centers for Disease Control and Prevention (CDC) is closely monitoring an outbreak caused by a novel (new) coronavirus in Wuhan City\, Hubei Province\, China. A number of countries\, including the U.S.\, are actively screening incoming travelers from Wuhan. \nStarting January 21\, 2020\, CDC’s 2019 Novel Coronavirus (2019-nCoV) response team will host a series of national calls to continue providing state and local partners with the latest information on the novel coronavirus outbreak and U.S. preparedness efforts. \nThe call schedule is currently set as follows: \n\n21 January 2:00-3:00pm EST\n27 January 2:00-3:00pm EST\n3 February 2:00-3:00pm EST\n10 February 2:00-3:00pm EST\n24 February 2:00-3:00pm EST\n2 March 2:00-3:00pm EST\n\n  \nParticipant Information \nBridgeline: \n1(800)-857-6697 Participant \nPasscode: 1324420 \nIf you have any questions about the call series\, please contact the CDC State Coordination Task Force (SCTF) – Operations. \nh/t NACCHO for originally posting this information.
URL:https://globalbiodefense.com/event/cdc-national-call-series-on-novel-coronavirus-monitoring-preparedness-3/
CATEGORIES:Government Hosted,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200203T140000
DTEND;TZID=America/New_York:20200203T150000
DTSTAMP:20200126T190909Z
CREATED:20200126T190529Z
LAST-MODIFIED:20200126T190909Z
UID:37776-1580738400-1580742000@globalbiodefense.com
SUMMARY:CDC National Call Series on Novel Coronavirus Monitoring & Preparedness
DESCRIPTION:The Centers for Disease Control and Prevention (CDC) is closely monitoring an outbreak caused by a novel (new) coronavirus in Wuhan City\, Hubei Province\, China. A number of countries\, including the U.S.\, are actively screening incoming travelers from Wuhan. \nStarting January 21\, 2020\, CDC’s 2019 Novel Coronavirus (2019-nCoV) response team will host a series of national calls to continue providing state and local partners with the latest information on the novel coronavirus outbreak and U.S. preparedness efforts. \nThe call schedule is currently set as follows: \n\n21 January 2:00-3:00pm EST\n27 January 2:00-3:00pm EST\n3 February 2:00-3:00pm EST\n10 February 2:00-3:00pm EST\n24 February 2:00-3:00pm EST\n2 March 2:00-3:00pm EST\n\n  \nParticipant Information \nBridgeline: \n1(800)-857-6697 Participant \nPasscode: 1324420 \nIf you have any questions about the call series\, please contact the CDC State Coordination Task Force (SCTF) – Operations. \nh/t NACCHO for originally posting this information.
URL:https://globalbiodefense.com/event/cdc-national-call-series-on-novel-coronavirus-monitoring-preparedness-2/
CATEGORIES:Government Hosted,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200123
DTEND;VALUE=DATE:20200125
DTSTAMP:20200105T182855Z
CREATED:20191205T175457Z
LAST-MODIFIED:20200105T182855Z
UID:36104-1579737600-1579910399@globalbiodefense.com
SUMMARY:National Science Advisory Board for Biosecurity (NSABB) Meeting
DESCRIPTION:The National Science Advisory Board for Biosecurity (NSABB) will convene 23-24 January 2020 in Bethesda\, Md. \nThe meeting will be open to the public\, with attendance limited to space available. The meeting will also be videocast. \nJanuary 23: 12:30 PM – 5 PM Eastern\nJanuary 24: 9 AM – 2:30 PM Eastern \nThe purpose of this meeting is to discuss considerations regarding security and public transparency when sharing information about research involving enhanced potential pandemic pathogens; as well as other business of the Board. \nIf you plan to attend the meeting in person please pre-register HERE.\nIndividuals in attendance may also register onsite on the day of the meeting.\nDraft Agenda will be posted when available. \nVideocasts: \n\nDay 1 – Link will be available on January 23\, 2020\nDay 2 – Link will be available on January 24\, 2020\n\nPlease visit the website for more information: http://bit.ly/NSABB-Meetings \nCurrent Voting Board Members\nMargie D. Lee\, DVM\, PhD*\nProfessor and Head\, Department of Biomedical Sciences and Pathobiology\nVirginia-Maryland College of Veterinary Medicine\nVirginia Tech \nStephen S. Morse\, PhD*\nDirector\, Infectious Disease Epidemiology Certificate Program\nProfessor of Epidemiology\nMailman School of Public Health\nColumbia University \nJean L. Patterson\, PhD\nProfessor\, Virology and Immunology Chair\, BSL-4 Task Force\nTexas Biomedical Research Institute \nRozanne M. Sandri-Goldin\, PhD\nProfessor and Chair\, Department of Microbiology and\nMolecular Genetics\nUniversity of California Irvine School of Medicine \nKenneth Bernard\, MD\nRADM\, U.S. Public Health Service (Ret.)\nFormer Special Assistant to the President for Biodefense\, Homeland Security Council\, White House\nFormer Special Adviser for Health and Security on the National Security Council \nCraig E. Cameron\, PhD\nJeffrey Houpt Distinguished Investigator\nChair\, Department of Microbiology and Immunology\nUniversity of North Carolina Chapel Hill School of Medicine \nMark Denison\, MD\nProfessor and Chair of Pediatrics\nAssociate Professor of Microbiology and Immunology\nVanderbilt University School of Medicine \nJohn D. Grabenstein\, RPh\, PhD\nSenior Medical Director\, Adult Vaccines\nMerck Vaccine Division\nMerck & Co.\, Inc. \nMarie-Louise Hammarskjöld\, MD\, PhD\nCharles H. Ross Jr. Professor and Professor of Microbiology\, Immunology\, and Cancer Biology\nAssociate Director\, Myles H. Thaler Center\nUniversity of Virginia School of Medicine \nJames W. LeDuc\, PhD\nDirector\, Galveston National Laboratory\nProfessor\, Department of Microbiology and Immunology\nUniversity of Texas Medical Branch
URL:https://globalbiodefense.com/event/national-science-advisory-board-for-biosecurity-nsabb-meeting/
LOCATION:Hyatt Regency Bethesda\, One Bethesda Metro Center\, Bethesda\, MD\, 20814\, United States
CATEGORIES:Conference,Government Hosted,Webinar-Webcast
END:VEVENT
END:VCALENDAR